Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 1 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2022 Filed Oct 4, 2022 13:41 UTC |
HILZINGER KURT JDirector
|
GrantRestricted Stock Units · Derivative | 191 | $492.23 | $94,015.93 |
DisclosureSEC source: 0001062993-22-020226 · form4.xml · derivative · entry 4 HILZINGER KURT J · CIK 0001191504 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,830 Underlying: Humana Common · 174 shares Expires not disclosed F3 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Read SEC document |
| September 20, 2022 Filed Sep 22, 2022 18:51 UTC |
Ventura Joseph CChief Legal Officer
|
GiftHumana Common | 61 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019857 · form4.xml · nonDerivative · entry 2 Ventura Joseph C · CIK 0001768291 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,869 F11 · shares: Shares disposed of represent a gift/charitable donation effective September 20, 2022 in which no value was received in return. Read SEC document |
| September 20, 2022 Filed Sep 22, 2022 18:51 UTC |
Ventura Joseph CChief Legal Officer
|
SaleHumana Common | 1,226 | $506.78 | $621,313.26 |
DisclosureSEC source: 0001062993-22-019857 · form4.xml · nonDerivative · entry 1 Ventura Joseph C · CIK 0001768291 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,930 F10 · shares: Price reported is average sales price. Read SEC document |
| September 20, 2022 Filed Oct 5, 2022 17:23 UTC |
Huval Timothy S.Chief Administrative Officer
|
Exercise / conversionOptions · Derivative | 1,667 | $0.00 Strike: $376.61 | $0.00 |
DisclosureSEC source: 0001062993-22-020494 · form4.xml · derivative · entry 8 Huval Timothy S. · CIK 0001565717 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,336 Underlying: Humana Common · 1,667 shares Expires 2028-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/22/2021, vesting in three annual increments from 2/22/22 to 2/22/24. F3 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/22/2021, vesting in three annual increments from 2/22/22 to 2/22/24. Read SEC document |
| September 20, 2022 Filed Oct 5, 2022 17:23 UTC |
Huval Timothy S.Chief Administrative Officer
|
Exercise / conversionOptions · Derivative | 4,058 | $0.00 Strike: $350.79 | $0.00 |
DisclosureSEC source: 0001062993-22-020494 · form4.xml · derivative · entry 7 Huval Timothy S. · CIK 0001565717 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,030 Underlying: Humana Common · 4,058 shares Expires 2027-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments from 2/24/21 to 2/24/23. F2 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments from 2/24/21 to 2/24/23. Read SEC document |
| September 20, 2022 Filed Oct 5, 2022 17:23 UTC |
Huval Timothy S.Chief Administrative Officer
|
Exercise / conversionOptions · Derivative | 1,712 | $0.00 Strike: $307.97 | $0.00 |
DisclosureSEC source: 0001062993-22-020494 · form4.xml · derivative · entry 6 Huval Timothy S. · CIK 0001565717 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 324 Underlying: Humana Common · 1,712 shares Expires 2026-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Right to buy pursuant to the Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/25/19, vesting in three increments from 02/25/20 to 02/25/22. F1 · derivative.exercise_date: Right to buy pursuant to the Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/25/19, vesting in three increments from 02/25/20 to 02/25/22. Read SEC document |
| September 20, 2022 Filed Oct 5, 2022 17:23 UTC |
Huval Timothy S.Chief Administrative Officer
|
SaleHumana Common | 7,437 | $505.51 | $3,759,442.17 |
DisclosureSEC source: 0001062993-22-020494 · form4.xml · nonDerivative · entry 5 Huval Timothy S. · CIK 0001565717 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,968 F10 · price: Price reported is weighted average sales price. Read SEC document |
| September 20, 2022 Filed Oct 5, 2022 17:23 UTC |
Huval Timothy S.Chief Administrative Officer
|
Exercise / conversionHumana Common | 1,667 | $376.61 | $627,808.87 |
DisclosureSEC source: 0001062993-22-020494 · form4.xml · nonDerivative · entry 4 Huval Timothy S. · CIK 0001565717 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,405 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 20, 2022 Filed Oct 5, 2022 17:23 UTC |
Huval Timothy S.Chief Administrative Officer
|
Exercise / conversionHumana Common | 4,058 | $350.79 | $1,423,495.68 |
DisclosureSEC source: 0001062993-22-020494 · form4.xml · nonDerivative · entry 3 Huval Timothy S. · CIK 0001565717 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,738 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 20, 2022 Filed Oct 5, 2022 17:23 UTC |
Huval Timothy S.Chief Administrative Officer
|
Exercise / conversionHumana Common | 1,712 | $307.97 | $527,236.08 |
DisclosureSEC source: 0001062993-22-020494 · form4.xml · nonDerivative · entry 2 Huval Timothy S. · CIK 0001565717 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,680 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 20, 2022 Filed Oct 5, 2022 17:23 UTC |
Huval Timothy S.Chief Administrative Officer
|
GiftHumana Common | 800 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-020494 · form4.xml · nonDerivative · entry 1 Huval Timothy S. · CIK 0001565717 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,968 F9 · shares: Shares disposed of represent a gift/charitable donation, effective September 20, 2022, in which no value was received in return. Read SEC document |
| September 20, 2022 Filed Nov 7, 2022 18:56 UTC |
BROUSSARD BRUCE DDirector · President & CEO
|
GiftHumana Common | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-021636 · form4.xml · nonDerivative · entry 12 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,602 F15 · shares: Shares represent a charitable gift/donation, effective September 20, 2022, in which no value was received in return. Read SEC document |
| September 20, 2022 Filed Nov 7, 2022 18:56 UTC |
BROUSSARD BRUCE DDirector · President & CEO
|
GiftHumana Common | 2,981 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-021636 · form4.xml · nonDerivative · entry 11 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,602 F14 · shares: Shares transferred represent a gift to a Trust in the name of affiliate's daughter, effective September 20, 2022. Affiliate is not a Trustee and has no pecuniary interest or investment discretion. Read SEC document |
| September 20, 2022 Filed Nov 7, 2022 18:56 UTC |
BROUSSARD BRUCE DDirector · President & CEO
|
GiftHumana Common | 2,981 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-021636 · form4.xml · nonDerivative · entry 10 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,583 F13 · shares: Shares transferred represent a gift to a Trust in the name of affiliate's son, effective September 20, 2022. Affiliate is not a Trustee and has no pecuniary interest or investment discretion. Read SEC document |
| September 15, 2022 Filed Sep 19, 2022 15:15 UTC |
SMITH BRAD DDirector
|
GrantRestricted Stock Units · Derivative | 386 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019666 · form4.xml · derivative · entry 2 SMITH BRAD D · CIK 0001284323 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 386 Underlying: Humana Common · 386 shares Expires not disclosed F1 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F2 · derivative.exercise_date: Initial award of $190,000 worth of restricted stock units pursuant to the annual Director Compensation Program. 100% of the award will vest on 9/15/2023 and forfeited in its entirety if service is less than one year. F2 · derivative.expiration_date: Initial award of $190,000 worth of restricted stock units pursuant to the annual Director Compensation Program. 100% of the award will vest on 9/15/2023 and forfeited in its entirety if service is less than one year. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 17:52 UTC |
Schick Susan D.Seg Pres. Grp. & Military Bus.
|
Exercise / conversionRestricted Stock Units · Derivative | 144 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019192 · form4.xml · derivative · entry 8 Schick Susan D. · CIK 0001881150 · Seg Pres. Grp. & Military Bus. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 290 Underlying: Humana Common · 144 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F3 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7 · derivative.exercise_date: Restricted stock units granted to reporting person on 9/1/2021, 33% of the award is vesting on 9/1/22, 9/1/23, and 9/1/24. F7 · derivative.expiration_date: Restricted stock units granted to reporting person on 9/1/2021, 33% of the award is vesting on 9/1/22, 9/1/23, and 9/1/24. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 17:52 UTC |
Schick Susan D.Seg Pres. Grp. & Military Bus.
|
Tax withholdingHumana Common | 45 | $484.12 | $21,785.18 |
DisclosureSEC source: 0001062993-22-019192 · form4.xml · nonDerivative · entry 2 Schick Susan D. · CIK 0001881150 · Seg Pres. Grp. & Military Bus. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,450 F9 · shares: Disposition represents shares withheld for taxes on the vesting. No open market sale or value received in return. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 17:52 UTC |
Schick Susan D.Seg Pres. Grp. & Military Bus.
|
Exercise / conversionHumana Common | 144 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019192 · form4.xml · nonDerivative · entry 1 Schick Susan D. · CIK 0001881150 · Seg Pres. Grp. & Military Bus. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,495 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2022 Filed Aug 3, 2022 13:33 UTC |
Felter John-Paul W.SVP, Chief Accting Off & Cont.
|
GrantRestricted Stock Units · Derivative | 631 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-017127 · form4.xml · derivative · entry 2 Felter John-Paul W. · CIK 0001936662 · SVP, Chief Accting Off & Cont. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 631 Underlying: Humana Common · 631 shares Expires not disclosed F1 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F1 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F2 · derivative.exercise_date: Restricted stock units granted to reporting person on 8/1/2022, 33% of the award is vesting on 8/1/23, 8/1/24, and 8/1/25. F2 · derivative.expiration_date: Restricted stock units granted to reporting person on 8/1/2022, 33% of the award is vesting on 8/1/23, 8/1/24, and 8/1/25. Read SEC document |
| August 01, 2022 Filed Aug 3, 2022 17:22 UTC |
Diamond Susan MChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 311 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-017153 · form4.xml · derivative · entry 10 Diamond Susan M · CIK 0001782445 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 622 Underlying: Humana Common · 311 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F9 · derivative.exercise_date: Restricted stock units granted to reporting person on 08/1/2021, 33% of the award is vesting on 8/1/22, 8/1/23, and 8/1/24. F9 · derivative.expiration_date: Restricted stock units granted to reporting person on 08/1/2021, 33% of the award is vesting on 8/1/22, 8/1/23, and 8/1/24. Read SEC document |
| August 01, 2022 Filed Aug 3, 2022 17:22 UTC |
Diamond Susan MChief Financial Officer
|
Tax withholdingHumana Common | 145 | $475.64 | $68,967.08 |
DisclosureSEC source: 0001062993-22-017153 · form4.xml · nonDerivative · entry 2 Diamond Susan M · CIK 0001782445 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,962 F12 · shares: Shares disposed of represent taxes withheld on the vesting. Read SEC document |
| August 01, 2022 Filed Aug 3, 2022 17:22 UTC |
Diamond Susan MChief Financial Officer
|
Exercise / conversionHumana Common | 311 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-017153 · form4.xml · nonDerivative · entry 1 Diamond Susan M · CIK 0001782445 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,107 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 19:26 UTC |
Diamond Susan MChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 291 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-016049 · form4.xml · derivative · entry 9 Diamond Susan M · CIK 0001782445 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 291 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7 · derivative.exercise_date: Restricted stock units granted to reporting person on 07/01/19, 33% of the award is vesting on 07/01/20, 07/01/21, and 07/01/22. F7 · derivative.expiration_date: Restricted stock units granted to reporting person on 07/01/19, 33% of the award is vesting on 07/01/20, 07/01/21, and 07/01/22. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 19:26 UTC |
Diamond Susan MChief Financial Officer
|
Tax withholdingHumana Common | 136 | $471.48 | $64,120.60 |
DisclosureSEC source: 0001062993-22-016049 · form4.xml · nonDerivative · entry 2 Diamond Susan M · CIK 0001782445 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,921 F13 · shares: Shares disposed of represent taxes withheld on the vesting. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 19:26 UTC |
Diamond Susan MChief Financial Officer
|
Exercise / conversionHumana Common | 291 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-016049 · form4.xml · nonDerivative · entry 1 Diamond Susan M · CIK 0001782445 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,057 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 13:38 UTC |
HILZINGER KURT JDirector
|
GrantRestricted Stock Units · Derivative | 191 | $468.33 | $89,451.03 |
DisclosureSEC source: 0001062993-22-015806 · form4.xml · derivative · entry 4 HILZINGER KURT J · CIK 0001191504 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,656 Underlying: Humana Common · 191 shares Expires not disclosed F3 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Read SEC document |
| June 22, 2022 Filed Jul 6, 2022 19:26 UTC |
Diamond Susan MChief Financial Officer
|
GiftHumana Common | 125 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-016049 · form4.xml · nonDerivative · entry 3 Diamond Susan M · CIK 0001782445 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,796 F14 · shares: Shares reported represent a gift/charitable donation effective June 22, 2022, in which no value was received in return. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 15:01 UTC |
Diamond Susan MChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,023 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-014250 · form4.xml · derivative · entry 8 Diamond Susan M · CIK 0001782445 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 1,023 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7 · derivative.exercise_date: Restricted stock units granted to reporting person on 06/01/19, 100% of the award is vesting on 6/1/22. F7 · derivative.expiration_date: Restricted stock units granted to reporting person on 06/01/19, 100% of the award is vesting on 6/1/22. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 15:01 UTC |
Diamond Susan MChief Financial Officer
|
Tax withholdingHumana Common | 477 | $451.08 | $215,162.78 |
DisclosureSEC source: 0001062993-22-014250 · form4.xml · nonDerivative · entry 2 Diamond Susan M · CIK 0001782445 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,766 F15 · shares: Shares disposed of represent taxes withheld on the vesting. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 15:01 UTC |
Diamond Susan MChief Financial Officer
|
Exercise / conversionHumana Common | 1,023 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-014250 · form4.xml · nonDerivative · entry 1 Diamond Susan M · CIK 0001782445 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,243 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F14 · balance_after: Reporting person transferred a total of 600 shares of direct ownership on May 2, 2022 pursuant to a Domestic Relations Order. Reporting person was afforded a filing exemption under Rule 16a-12, which extends to securities transferred under a DRO. Read SEC document |
| May 03, 2022 Filed May 4, 2022 20:33 UTC |
Deshpande SamirChief Information Officer
|
SaleHumana Common | 3,957 | $434.19 | $1,718,100.51 |
DisclosureSEC source: 0001062993-22-011545 · form4.xml · nonDerivative · entry 1 Deshpande Samir · CIK 0001712481 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,529 F10 · price: All shares sold at reported price. Read SEC document |
| May 01, 2022 Filed May 3, 2022 17:45 UTC |
Shrank William HChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 504 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-011349 · form4.xml · derivative · entry 9 Shrank William H · CIK 0001772348 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 504 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_date: Restricted stock units granted to reporting person on 5/1/19, 33% of the award is vesting on 5/1/20, 5/1/21, and 5/1/22. F6 · derivative.expiration_date: Restricted stock units granted to reporting person on 5/1/19, 33% of the award is vesting on 5/1/20, 5/1/21, and 5/1/22. Read SEC document |
| May 01, 2022 Filed May 3, 2022 17:45 UTC |
Shrank William HChief Medical Officer
|
Tax withholdingHumana Common | 164 | $449.81 | $73,769.58 |
DisclosureSEC source: 0001062993-22-011349 · form4.xml · nonDerivative · entry 4 Shrank William H · CIK 0001772348 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,294 F11 · shares: Shares disposed of represent withholding of taxes on restricted/performance stock unit vesting. Read SEC document |
| May 01, 2022 Filed May 3, 2022 17:45 UTC |
Shrank William HChief Medical Officer
|
Exercise / conversionHumana Common | 504 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-011349 · form4.xml · nonDerivative · entry 3 Shrank William H · CIK 0001772348 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,458 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2022 Filed May 3, 2022 17:45 UTC |
Shrank William HChief Medical Officer
|
Tax withholdingHumana Common | 2,250 | $449.81 | $1,012,082.63 |
DisclosureSEC source: 0001062993-22-011349 · form4.xml · nonDerivative · entry 2 Shrank William H · CIK 0001772348 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,954 F11 · shares: Shares disposed of represent withholding of taxes on restricted/performance stock unit vesting. Read SEC document |
| May 01, 2022 Filed May 3, 2022 17:45 UTC |
Shrank William HChief Medical Officer
|
Exercise / conversionHumana Common | 4,926 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-011349 · form4.xml · nonDerivative · entry 1 Shrank William H · CIK 0001772348 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,204 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · shares: Includes Performance Stock Units, not required to be reported until vest. Read SEC document |
| April 28, 2022 Filed May 2, 2022 17:34 UTC |
Fleming William KevinSeg Pres, Pharmacy Sol & CCAO
|
SaleHumana Common | 3,210 | $449.68 | $1,443,470.55 |
DisclosureSEC source: 0001062993-22-011163 · form4.xml · nonDerivative · entry 2 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 884 F13 · price: Price reported is weighted average sales price. Read SEC document |
| April 28, 2022 Filed May 2, 2022 17:34 UTC |
Fleming William KevinSeg Pres, Pharmacy Sol & CCAO
|
GiftHumana Common | 663 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-011163 · form4.xml · nonDerivative · entry 1 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,094 F12 · shares: Shares disposed of represent gift/charitable donation, effective April 28, 2022, in which no value was received in return. Read SEC document |
| April 28, 2022 Filed May 2, 2022 17:26 UTC |
Huval Timothy S.Chief Administrative Officer
|
SaleHumana Common | 3,477 | $443.14 | $1,540,797.78 |
DisclosureSEC source: 0001062993-22-011159 · form4.xml · nonDerivative · entry 2 Huval Timothy S. · CIK 0001565717 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,768 F10 · price: Price reported is weighted average sales price. Read SEC document |
| April 28, 2022 Filed Dec 23, 2022 15:18 UTC |
JONES DAVID A JR/KYDirector
|
GiftHumana Common | 11,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-024440 · form4.xml · nonDerivative · entry 3 JONES DAVID A JR/KY · CIK 0001025393 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 57,028 F6 · shares: Shares disposed of represent gift/charitable donation effective April 28, 2022, in which no value was received in return. F4 · ownership.nature: Shares held by a revocable trust account (Dec 2009), on which reporting person is the sole trustee, holding certain shares of Humana Inc. common stock. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 15:34 UTC |
HILZINGER KURT JDirector
|
GrantRestricted Stock Units · Derivative | 209 | $440.06 | $91,971.50 |
DisclosureSEC source: 0001062993-22-009313 · form4.xml · derivative · entry 4 HILZINGER KURT J · CIK 0001191504 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,465 Underlying: Humana Common · 209 shares Expires not disclosed F3 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Read SEC document |
| March 22, 2022 Filed Mar 24, 2022 14:33 UTC |
Wheatley Timothy AlanSegment President, Retail
|
OtherPhantom Stock Units · Derivative | 10 | $438.43 | $4,384.30 |
DisclosureSEC source: 0001062993-22-008461 · form4.xml · derivative · entry 12 Wheatley Timothy Alan · CIK 0001699799 · Segment President, Retail 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 161 Underlying: Humana Common · 10 shares Expires not disclosed F12 · security: Phantom Stock Units held for the benefit of reporting person as of March 22, 2022 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. F12 · derivative.exercise_price: Phantom Stock Units held for the benefit of reporting person as of March 22, 2022 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. F12 · derivative.exercise_date: Phantom Stock Units held for the benefit of reporting person as of March 22, 2022 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. F12 · derivative.expiration_date: Phantom Stock Units held for the benefit of reporting person as of March 22, 2022 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. F12 · ownership.nature: Phantom Stock Units held for the benefit of reporting person as of March 22, 2022 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. Read SEC document |
| March 22, 2022 Filed Mar 24, 2022 14:28 UTC |
Zipperle Cynthia HSVP, Chief Acct Officer & Cont
|
OtherPhantom Stock Units · Derivative | 9 | $438.43 | $3,945.87 |
DisclosureSEC source: 0001062993-22-008459 · form4.xml · derivative · entry 5 Zipperle Cynthia H · CIK 0001628102 · SVP, Chief Acct Officer & Cont 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 302 Underlying: Humana Common · 9 shares Expires not disclosed F5 · security: Phantom Stock Units held for the benefit of reporting person as of March 22, 2022 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. F5 · derivative.exercise_price: Phantom Stock Units held for the benefit of reporting person as of March 22, 2022 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. F5 · derivative.exercise_date: Phantom Stock Units held for the benefit of reporting person as of March 22, 2022 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. F5 · derivative.expiration_date: Phantom Stock Units held for the benefit of reporting person as of March 22, 2022 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. F5 · ownership.nature: Phantom Stock Units held for the benefit of reporting person as of March 22, 2022 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. Read SEC document |
| March 15, 2022 Filed May 2, 2022 17:26 UTC |
Huval Timothy S.Chief Administrative Officer
|
GiftHumana Common | 439 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-011159 · form4.xml · nonDerivative · entry 1 Huval Timothy S. · CIK 0001565717 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,245 F9 · shares: Shares disposed of represent a gift/charitable donation, effective March 15, 2022, in which no value was received in return. Read SEC document |
| March 03, 2022 Filed Sep 22, 2022 18:51 UTC |
Ventura Joseph CChief Legal Officer
|
GiftHumana Common | 70 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019857 · form4.xml · nonDerivative · entry 3 Ventura Joseph C · CIK 0001768291 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,799 F12 · shares: Shares disposed of represent a gift/charitable donation effective March 3, 2022 in which no value was received in return. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 16:30 UTC |
Agwunobi, M.D. Andrew C.Seg. President, Home Solutions
|
GrantRestricted Stock Units · Derivative | 784 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-006530 · form4.xml · derivative · entry 3 Agwunobi, M.D. Andrew C. · CIK 0001365029 · Seg. President, Home Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 784 Underlying: Humana Common · 784 shares Expires not disclosed F2 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F2 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F3 · derivative.exercise_date: Restricted stock units granted to reporting person on 3/1/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. F3 · derivative.expiration_date: Restricted stock units granted to reporting person on 3/1/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 16:30 UTC |
Agwunobi, M.D. Andrew C.Seg. President, Home Solutions
|
GrantOptions · Derivative | 3,086 | $0.00 Strike: $430.62 | $0.00 |
DisclosureSEC source: 0001062993-22-006530 · form4.xml · derivative · entry 2 Agwunobi, M.D. Andrew C. · CIK 0001365029 · Seg. President, Home Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,086 Underlying: Humana Common · 3,086 shares Expires 2029-03-01 F1 · security: Right to buy pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 3/1/2022, vesting in three annual increments from 3/1/23 to 3/1/25. F1 · derivative.exercise_date: Right to buy pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 3/1/2022, vesting in three annual increments from 3/1/23 to 3/1/25. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 16:29 UTC |
Feinberg David TDirector
|
GrantRestricted Stock Units · Derivative | 441 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-006528 · form4.xml · derivative · entry 2 Feinberg David T · CIK 0001486426 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 441 Underlying: Humana Common · 441 shares Expires not disclosed F1 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F2 · derivative.exercise_date: Initial award of $190,000 worth of restricted stock units pursuant to the annual Director Compensation Program. 100% of the award will vest on 3/1/2023 and forfeited in its entirety if service is less than one year. F2 · derivative.expiration_date: Initial award of $190,000 worth of restricted stock units pursuant to the annual Director Compensation Program. 100% of the award will vest on 3/1/2023 and forfeited in its entirety if service is less than one year. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:35 UTC |
Diamond Susan MChief Financial Officer
|
Tax withholdingHumana Common | 437 | $428.27 | $187,153.99 |
DisclosureSEC source: 0001062993-22-006127 · form4.xml · nonDerivative · entry 2 Diamond Susan M · CIK 0001782445 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,820 F15 · shares: Disposition reported represents shares withheld for payment of tax liability associated with vesting of Performance Stock Units on 2/25/22. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:35 UTC |
Diamond Susan MChief Financial Officer
|
Exercise / conversionHumana Common | 1,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-006127 · form4.xml · nonDerivative · entry 1 Diamond Susan M · CIK 0001782445 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,257 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F14 · shares: Performance Stock Units vested on 2/25/22, not required to be reported until vest. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.